John Maraganore - 10 Dec 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ALNY
Reported as of: 10 Dec 2021
Net transaction value: +$399,829
SEC form: 4
Accepted by SEC: 14 Dec 2021, 15:05:49 UTC
Prior SEC filing: 12 Nov 2021
Next SEC filing: 23 Dec 2021
Source filing: View source filing
Reporting owner signature: By: /s/ Mary Beth DeLena, Attorney-in-Fact For: John M. Maraganore

Key filing fact

John Maraganore filed Form 4 for ALNYLAM PHARMACEUTICALS, INC. (ALNY) on 14 Dec 2021.

Key facts

This page summarizes John Maraganore's Form 4 filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY).
8 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 14 Dec 2021, 15:05.

Change

Previous filing in this sequence was filed on 12 Nov 2021.
Current net transaction value: +$399,829.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALNY transaction

Common Stock

Options Exercise

Transaction value: $99,922
Shares: +1,036
Change %: +0.48%
Price: $96.45
Shares after: 215,801
Date: 10 Dec 2021
Ownership: Direct

ALNY transaction

Common Stock

Options Exercise

Transaction value: $99,980
Shares: +1,124
Change %: +0.52%
Price: $88.95
Shares after: 216,925
Date: 10 Dec 2021
Ownership: Direct

ALNY transaction

Common Stock

Options Exercise

Transaction value: $99,950
Shares: +839
Change %: +0.39%
Price: $119.13
Shares after: 217,764
Date: 10 Dec 2021
Ownership: Direct

ALNY transaction

Common Stock

Options Exercise

Transaction value: $99,977
Shares: +2,368
Change %: +1.1%
Price: $42.22^*
Shares after: 220,132
Date: 10 Dec 2021
Ownership: Direct

ALNY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,133
Date: 10 Dec 2021
Ownership: by Managed Account
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALNY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -2,368
Change %: -9.5%
Price: $0.000000
Shares after: 22,632
Date: 10 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,368
Exercise price: $42.22
Footnotes: F2

ALNY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -1,124
Change %: -1.7%
Price: $0.000000
Shares after: 63,876
Date: 10 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,124
Exercise price: $88.95
Footnotes: F2

ALNY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -1,036
Change %: -1.4%
Price: $0.000000
Shares after: 73,964
Date: 10 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,036
Exercise price: $96.45
Footnotes: F2

ALNY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -839
Change %: -1.6%
Price: $0.000000
Shares after: 51,661
Date: 10 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 839
Exercise price: $119.13
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.

Footnote F2

The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Footnote F3

The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to the remaining shares ratably at the end of each three-month period thereafter over the following thirty-three (33) months.